Aspeya Email Format
Pharmaceutical ManufacturingConnecticut, United States51-200 Employees
Aspeya is a pharmaceutical manufacturing company based in Stamford, Connecticut, United States, with 51-200 employees and a website at https://aspeya.com. The company focuses on three areas—consumer wellness, cannabinoids, and inhaled therapeutics—and is developing a pipeline of wellness and healthcare products and brands guided by scientific substantiation. It emphasizes optimizing formulas and applying rigorous scientific standards to rethink how ingredients can be used. Aspeya operates internationally, including Aspeya Switzerland SA, which announced two clinical trials in May 2026 evaluating ASY202, an inhaled formulation of dihydroergotamine mesylate for migraine and pulmonary safety. In May 2026, Aspeya announced a partnership with Atlantic Grupa.